quinoxalines has been researched along with Allergic Contact Dermatitis in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 8 (88.89) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (11.11) | 2.80 |
Authors | Studies |
---|---|
Bourgault, S; Houle, MC; Lajoie, C; Ringuet, J; Simonyan, D | 1 |
Beck, LA; Borregaard, J; Clucas, A; Skov, L; Sonne, J; Ting, N; Wang, C; Wang, L | 1 |
Ratan, J; Sodhi, PK; Verma, L | 1 |
Bonini, S; Bucci, MG; Centofanti, M; Manni, G; Oddone, F; Parravano, M; Sacchetti, M | 1 |
Spaeth, GL | 1 |
Gross, RL; Orengo-Nania, S; Williams, GC | 1 |
Blondeau, P; Rousseau, JA | 1 |
Bazex, J; Belhadjali, H; Giordano-Labadie, F; Journé, F; Lefebvre, H; Marguery, MC | 1 |
García-Díez, A; López, MP; Sánchez-Pérez, J | 1 |
1 trial(s) available for quinoxalines and Allergic Contact Dermatitis
Article | Year |
---|---|
Evaluation of the effect of the specific CCR1 antagonist CP-481715 on the clinical and cellular responses observed following epicutaneous nickel challenge in human subjects.
Topics: Dermatitis, Allergic Contact; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Irritants; Male; Nickel; Quinoxalines; Receptors, CCR1 | 2008 |
8 other study(ies) available for quinoxalines and Allergic Contact Dermatitis
Article | Year |
---|---|
The benefit of scratch patch testing to demonstrate ocular contact allergy to brimonidine tartrate.
Topics: Adrenergic alpha-Agonists; Brimonidine Tartrate; Dermatitis, Allergic Contact; Humans; Patch Tests; Quinoxalines | 2022 |
Dermatological side effects of brimonidine: a report of three cases.
Topics: Administration, Topical; Adult; Aged; Antihypertensive Agents; Brimonidine Tartrate; Dermatitis, Allergic Contact; Diagnosis, Differential; Facial Dermatoses; Female; Glaucoma, Open-Angle; Humans; Lichen Planus; Male; Nail Diseases; Ocular Hypertension; Ophthalmic Solutions; Patch Tests; Quinoxalines | 2003 |
Demographic and clinical factors associated with development of brimonidine tartrate 0.2%-induced ocular allergy.
Topics: Adrenergic alpha-Agonists; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Brimonidine Tartrate; Conjunctivitis, Allergic; Demography; Dermatitis, Allergic Contact; Drug Hypersensitivity; Eyelid Diseases; Female; Glaucoma; Humans; Male; Middle Aged; Ophthalmic Solutions; Quinoxalines; Retrospective Studies; Risk Factors | 2004 |
Allergic contact dermatitis caused by topical eye drops.
Topics: Administration, Topical; Antihypertensive Agents; Blepharitis; Brimonidine Tartrate; Dermatitis, Allergic Contact; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Latanoprost; Middle Aged; Ophthalmic Solutions; Prostaglandins F, Synthetic; Quinoxalines | 2006 |
Incidence of brimonidine allergy in patients previously allergic to apraclonidine.
Topics: Adolescent; Adrenergic alpha-Agonists; Adult; Aged; Aged, 80 and over; Brimonidine Tartrate; Clonidine; Conjunctivitis; Cross Reactions; Dermatitis, Allergic Contact; Drug Hypersensitivity; Female; Glaucoma; Humans; Hyperemia; Incidence; Male; Middle Aged; Quinoxalines; Retrospective Studies; Risk Factors | 2000 |
Allergic reactions to brimonidine in patients treated for glaucoma.
Topics: Adrenergic alpha-Agonists; Aged; Antihypertensive Agents; Brimonidine Tartrate; Conjunctivitis, Allergic; Dermatitis, Allergic Contact; Drug Hypersensitivity; Female; Glaucoma; Humans; Levobunolol; Male; Quinoxalines; Retrospective Studies; Seasons | 2002 |
Allergic and photoallergic contact dermatitis to Olaquindox in a pig breeder with prolonged photosensitivity.
Topics: Animal Feed; Animal Husbandry; Animals; Anti-Infective Agents; Dermatitis, Allergic Contact; Dermatitis, Occupational; Dermatitis, Photoallergic; Food Additives; Humans; Male; Middle Aged; Quinoxalines; Swine; Swine Diseases | 2002 |
Airborne allergic contact dermatitis from olaquindox in a rabbit breeder.
Topics: Air Pollutants, Occupational; Animals; Breeding; Dermatitis, Allergic Contact; Dermatitis, Occupational; Humans; Male; Middle Aged; Patch Tests; Quinoxalines; Rabbits | 2002 |